Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.
about
Prioritizing therapeutic targets using patient-derived xenograft modelsOncDRS: An integrative clinical and genomic data platform for enabling translational research and precision medicineCirculating Tumor DNA as Biomarkers for Cancer Detection.Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.Converting biology into clinical benefit: lessons learned from BRAF inhibitors.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.
P2860
Q28083993-AEE00FD5-E4A5-4923-B840-81D6EE02EC03Q31070571-EDDBF3A4-0DA7-4F80-B361-C14BE33E7463Q33632125-8986B4AE-8665-49E2-8C3A-C5356373A99BQ34529131-0A98124A-2FC6-4112-AB6C-7E8BF9A2A539Q37383599-3CF71336-EC3A-4897-B86D-59A12194F431Q38940098-96DCE4C1-4084-469B-A178-A7D656A29F24Q48098689-636BD6EB-E61F-44E8-84A4-8AB5FF854F61
P2860
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Optimal design of trials to de ...... n Cancer Medicine to the test.
@en
type
label
Optimal design of trials to de ...... n Cancer Medicine to the test.
@en
prefLabel
Optimal design of trials to de ...... n Cancer Medicine to the test.
@en
P2860
P1433
P1476
Optimal design of trials to de ...... n Cancer Medicine to the test.
@en
P2093
Jordi Rodon
Rodrigo Dienstmann
P2860
P304
P356
10.1016/J.MOLONC.2014.06.014
P577
2014-07-15T00:00:00Z